Structure of full-length APOBEC3B bound to EBV BORF2 reveals coordinated neutralization of a cancer-associated mutator
This study presents a 2.77 Å cryo-EM structure of the full-length APOBEC3B complex with EBV BORF2, revealing how the virus neutralizes this cancer-associated mutator through the formation of an elongated hetero-octamer driven by coordinated dual-domain engagement that occludes the catalytic site and stabilizes higher-order BORF2 assemblies.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Imagine your body is a bustling city, and inside every building (your cells), there are security guards called APOBEC3 enzymes. Their job is to patrol the DNA blueprints, looking for intruders like viruses. When they spot a viral invader, they don't just arrest it; they scribble "corrections" on the viral DNA that turn it into gibberish, effectively destroying the virus's ability to replicate. However, these guards are so thorough that sometimes they get a little too excited and start scribbling on the city's own blueprints too. When this happens, it can cause the buildings to malfunction, leading to chaos like cancer.
Now, imagine a master thief (a virus) trying to break into this city. To succeed, the thief needs a way to trick the security guards into stopping their scribbling. One particularly clever thief, the Epstein-Barr Virus (EBV), has a special tool called BORF2. Think of BORF2 as a high-tech handcuff that can grab the security guard, stop them from writing, and drag them out of the building's control room into a holding cell in the basement. For a long time, scientists knew the handcuff existed and knew it grabbed the guard's main hand, but they didn't know exactly how the whole system fit together or how the thief managed to lock the guard away so effectively.
This new study acts like a high-resolution 3D blueprint of that exact moment of capture. Using a powerful microscope that can freeze molecules in time, researchers captured the full picture of the security guard (the full-length APOBEC3B protein) being held by the thief's tool (the EBV BORF2 protein). They discovered that the thief doesn't just use one handcuff; they use a complex, interlocking system. The BORF2 tool actually grabs the guard in two places at once: one hand holds the guard's main tool, and the other hand grabs the guard's other arm. This double grip forces the guards and the thieves to link up into long, chain-like filaments. These chains are so strong and organized that they trap the guards in a massive pile outside the control room, ensuring the virus's DNA stays safe.
The researchers found that this chain reaction is incredibly specific. If they broke just one of the connection points on the thief's tool, the whole chain fell apart, and the guards were left free to roam the building again. This suggests that the virus has evolved a very precise architectural trick: it doesn't just disable the guard; it recruits the guard to help build a giant, organized cage that keeps the guard busy and far away from the virus's secrets. While the study shows exactly how this cage is built, it also hints that this same mechanism might be why these guards sometimes cause trouble in human cells, turning a defense system into a source of mutation that drives cancer.
The Story of the Double-Handcuff Trap
In the world of biology, the battle between viruses and our immune system is a constant game of cat and mouse. The "cat" in this story is a protein called APOBEC3B (or A3B for short). A3B is a double-domain enzyme, meaning it has two distinct parts: a "head" (the N-terminal domain) that doesn't do any cutting but helps with grabbing, and a "body" (the C-terminal domain) that acts as a molecular scissors, snipping and altering DNA to stop viruses. While A3B is great at stopping viruses, it's also a double-edged sword. If it gets too active, it starts editing our own human DNA, which can lead to mutations and cancer.
The "mouse" is the Epstein-Barr Virus (EBV), a very common virus that causes mononucleosis and is linked to several types of cancer. EBV has a secret weapon: a protein called BORF2. Previous studies showed that BORF2 could grab onto the "body" of A3B and stop it from cutting DNA. But scientists were missing a crucial piece of the puzzle: they didn't know how the entire A3B protein (both head and body) looked when it was caught, or how BORF2 managed to neutralize it so completely. Did BORF2 just slap a handcuff on the scissors? Or was there a more complex dance happening?
The Blueprint of the Capture
To solve this mystery, the researchers mixed the full-length A3B protein with the BORF2 protein in a lab dish and used a technique called cryo-electron microscopy. This is like taking a super-fast, ultra-clear photo of molecules frozen in a block of ice. The result was a stunning 2.77 Å resolution structure (that's incredibly tiny, about the width of a few atoms) that revealed the secret architecture of the capture.
Here is what they found:
1. The Chain Gang
The virus doesn't just catch one guard; it builds a chain. The structure revealed a massive hetero-octamer, which is a fancy way of saying a complex made of eight parts: four A3B guards and four BORF2 thieves. These eight parts link up to form two smaller groups (tetramers) that then snap together to form a larger unit. Even more interestingly, these units can link up end-to-end to form long, filamentous chains, like a train of cars.
2. The Double Grip
The most surprising discovery was how BORF2 holds A3B. It's not a simple one-on-one grab.
- The Body Grab: The "body" of A3B (the catalytic part) is grabbed by BORF2 right at the spot where it would normally cut DNA. This blocks the scissors, rendering them useless.
- The Head Grab: But wait, there's more! The "head" of A3B (the part that was thought to be just a helper) reaches out and grabs a second BORF2 molecule.
This creates a "double-domain engagement." A3B is holding hands with BORF2 in two different places simultaneously. This dual grip is what stabilizes the whole structure.
3. The Lock and Key
The researchers discovered that BORF2 has two different ways it can link to other BORF2 molecules. One way is called the "non-canonical" interface (which was known before), and the other is a "canonical" interface (a standard way ribonucleotide reductases, the family BORF2 belongs to, usually link up).
In the presence of full-length A3B, the virus forces BORF2 to use this "canonical" interface to link up. The A3B protein acts like a bridge, connecting two BORF2 molecules together. Without the full A3B protein (specifically its "head"), this bridge doesn't form, and the chain falls apart.
What Happens When the Chain Breaks?
To prove that this chain structure was the key to the virus's success, the researchers played a game of "what if." They created mutant versions of BORF2 where they broke the connection points.
- The Broken Chain: When they mutated a specific part of BORF2 (changing a residue called Y245 to arginine), the "canonical" bridge couldn't form. When they mutated another part (R39E), the "non-canonical" bridge broke.
- The Result: In both cases, the long chains disappeared. Instead of forming a massive, organized filament, the proteins just floated around as small, isolated groups.
- The Cellular Proof: When they put these broken mutants into human cells, the magic stopped. The wild-type (normal) BORF2 successfully dragged A3B out of the cell's control center (the nucleus) and formed big, visible clumps in the cytoplasm. But the mutants? They failed. The A3B guards stayed free in the nucleus, and the virus couldn't hide its DNA.
Why This Matters
This study changes how we see the battle between EBV and our immune system. It turns out the virus doesn't just "turn off" the guard; it recruits the guard to build a giant, organized cage. By forcing A3B to stabilize the BORF2 chains, the virus effectively sequesters the mutator, keeping it away from the viral DNA it wants to protect.
The paper suggests that this mechanism is a clever evolutionary trick. The virus has turned a dangerous human protein (which causes cancer when it goes rogue) into a structural brick for its own defense system. While the study confirms the structure and the mechanism of sequestration, it also raises a fascinating question: Could this same "chain-building" behavior be part of why A3B causes cancer in the first place? The paper suggests that understanding this structure gives us a new framework to look at how viruses and cancer might be linked, but it stops short of claiming this is the only cause of cancer.
In short, the virus has built a molecular trap that is so effective it requires the victim to help build the cage. And now, thanks to this high-resolution blueprint, we can see exactly how the bars are made.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.